Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

Nguyen, Q D

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. [electronic resource] - The British journal of ophthalmology Oct 2005 - 1368-70 p. digital

Publication Type: Case Reports; Letter

0007-1161


Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Choroidal Neovascularization--drug therapy
Female
Humans
Male
Middle Aged
Myopia, Degenerative--complications
Vascular Endothelial Growth Factor A--antagonists & inhibitors